TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer

Key Takeaway: TriSalus Life Sciences is set to host a virtual Key Opinion Leader (KOL) event on June 24. The event will showcase new real-world evidence regarding their Pressure-Enabled Drug Delivery™ technology specifically for liver cancer treatment. This initiative highlights the company's commitment to advancing therapeutic options in oncology.